[1] | Paul M, Xu L, Wald MM, Coronado VG. Traumatic brain injury. www.cdc.gov/TraumaticBrainInjury. Updated 2010. Accessed 10/16, 2015. |
|
[2] | Giacino J, Kalmar K. Coma recovery scale-revised. The center for outcome measurement in brain injury. COMBI The Center for Outcome Measurement In Brain Injury Web site. http://www.tbims.org/combi/crs. Published May 14, 2016. Updated 2016. Accessed 5/14, 2016. |
|
[3] | Pistoia F, Mura E, Govoni S, Fini M, Sarà M. Awakenings and awareness recovery in disorders of consciousness: Is there a role for drugs? CNS Drugs. 2010; 24(8): 625-638. |
|
[4] | Seel RT, Douglas J, Dennison AC, Heaner S, Farris K, Rogers C. Specialized early treatment for persons with disorders of consciousness: Program components and outcomes. Arch Phys Med Rehabil. 2013; 94(10):1908-1923. |
|
[5] | Giacino J, Whyte J, Bagiella E, Kalmar K, Childs N, Khademi A. Placebo-controlled trial of amantadine for severe traumatic brain injury. New England Journal of Medicine. 2012; 366(9) (3/2012): 819-26. |
|
[6] | Whyte J. Disorders of consciousness: The changing landscape of treatment. Neurology. 2014; 82(13): 1106-1107. |
|
[7] | Ugoya SO, Akinyemi RO. The place of L-dopa/carbidopa in persistent vegetative state. Clin Neuropharmacol. 2010; 33(6): 279-284. |
|
[8] | Whyte J, Giacino J. Disorders of consciousness. In: Arciniegas DB, Zasler ND, Vanderploeg RD, Jaffee MS., ed. Management of adults with traumatic brain injury. 1st ed. Washington,DC: American Psychiatric Publishing; 2013:103-124. |
|
[9] | Dougall D, Poole N, Agrawal N. Pharmacotherapy for chronic cognitive impairment in traumatic brain injury. Cochrane Database of Systematic Reviews. 2015; 12. |
|
[10] | Talsky A, Pacione LR, Shaw T, et al. Pharmacological interventions for traumatic brain injury. BC Med J. 2010; 53: 26-31. |
|
[11] | Guidelines for the management of severe traumatic brain injury. Brain Trauma Foundation Web site. http://www.braintrauma.org/upload/06/06Guidelines_Management_2007. Updated 06, 2007. Accessed 10/09, 2015. |
|
[12] | Traumatic brain injury rates of TBI-related emergency department visits, hospitalizations, and deaths - united states, 2001-2010. Centers for Disease Control and Prevention Web site. https://www.cdc.gov/traumaticbraininjury/data/rates.html. Updated 2010. Accessed 10/16, 2015. |
|
[13] | Chew E, Zafonte R. Pharmacological management of neurobehavioral disorders following traumatic brain injury. Journal of Rehabilitation Research & Development. 2009; 46(04/30/2009): 851-78. |
|
[14] | Hughes S, Colantonio A, Santaguida PL, Paton T. Amantadine to enhance readiness for rehabilitation following severe traumatic brain injury. Brain Inj. 2009; 19 (14)(12/2005): 19197-206. |
|
[15] | Meythaler JM, Brunner RC, Johnson A, Novack TA. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: A pilot double-blind randomized trial. J Head Trauma Rehabil. 2002; 17(4):300-313. |
|
[16] | Leone H, Polsonetti BW. Amantadine for traumatic brain injury: Does it improve cognition and reduce agitation? J Clin Pharm Ther. 2005; 30(2): 101-104. |
|
[17] | Krimchansky BZ, Keren O, Sazbon L, Groswasser Z. Differential time and related appearance of signs, indicating improvement in the state of consciousness in vegetative state traumatic brain injury (VS-TBI) patients after initiation of dopamine treatment. Brain Inj. 2004; 18(11): 1099-1105. |
|
[18] | Fridman E, Krimchansky B, Bonetto M, Galperin T, Gamzu E, Leiguarda R. Continuous subcutaneous apomorphine for severe disorders of consciousness after traumatic brain injury. Allied Health; Biomedical; Europe UK & Ireland. 2010; 24(4)(04/2010): 636-41. |
|
[19] | Du B, Shan A, Zhang Y, Chen D, Cai K. Zolpidem arouses patients in vegetative state after brain injury: Quantitative evaluation and indications. PubMed-index for MEDLINE. 2014; 347(3)(03/2014): 178-82. |
|
[20] | Whyte J, Rajan R, Rosenbaum A, Katz D, Kalmar K, Sell R. Zolpidem and restoration of consciousness. American Journal Physician Medical Rehabilitation. 2014; 93(2)(02/2014): 101-13. |
|
[21] | Kim Y, Ko M, Na S, Park S, Kim K. Effects of single-dose methylphenidate on cognitive performance in patients with traumatic brain injury: A double-blind placebo-controlled study. University School of Medicine, Seoul, republic of Korea. 2006; 24(1/2012): 24-30. |
|
[22] | Kim J, Whyte J, Patel S, et al. Methylphenidate modulates sustained attention and cortical activation in survivors of traumatic brain injury: A perfusion fMRI study. Psychopharmacology (Berl). 2012; 222(1): 47-57. |
|
[23] | Krimchansky BZ, Keren O, Sazbon L, Groswasser Z. Differential time and related appearance of signs, indicating improvement in the state of consciousness in vegetative state traumatic brain injury (VS-TBI) patients after initiation of dopamine treatment. Brain Inj. 2004; 18(11): 1099-1105. |
|
[24] | Moein P, Ford SA, Asnaashari A, et al. The effect of boswellia serrata on neurorecovery following diffuse axonal injury. Brain Inj. 2013; 27(12): 1454-1460: 1454-1460. |
|
[25] | McAllister TW, Flashman LA, McDonald BC, et al. Dopaminergic challenge with bromocriptine one month after mild traumatic brain injury: Altered working memory and BOLD response. J Neuropsychiatry Clin Neurosci. 2011; 23(3): 277-286. |
|
[26] | Tyson B. Havelock's theory of change. Bright Hub Project Management Web site. http://www.brighthubpm.com/change-management/86803-havelocks-theory-of-change/. Updated 2010. Accessed 10/06, 2015. |
|